EP. 1: Second Opinion: Cancer and Cardiotoxicity
September 13th 2022
Cardiologist, Christopher Fine, MD and hematologist/oncologist Mohammed Salhab, MD discuss the management of cardiotoxicity resulting from immune checkpoint inhibitor therapy in patients with cancer.
EP. 2: Second Opinion: Breaking Down ADCES 22
September 1st 2022
In this episode of Second Opinion, Drs. Diana Isaacs and Natalie Bellini sit down to discuss the Association of Diabetes Care and Education Specialists 2022 annual meeting, which was held in Baltimore, MD, from August 12-15. The first in-person ADCES meeting since 2019, Isaacs and Bellini provide an overview of the conference, prevailing themes, and take a deep dive into their favorite sessions.
EP. 3: Second Opinion: CBD - The Legal Side of Cannabidiol
August 30th 2022
A discussion on the regulatory issues facing cannabidiol (CBD) and their sale.
EP. 4: Second Opinion: Careers in Academic Medicine
August 23rd 2022
Ruth Schneider and Adolfo Ramirez-Zamora join Second Opinion to discuss careers in academic medicine.
EP. 5: Second Opinion: Nutraceuticals in Veterinary Medicine
July 28th 2022
Dr. Robert Silver and Dr. Donna Raditic discuss nutraceuticals for pets covering their pros and cons, and the National Animal Supplement Council regulations. They also touch upon what further research is needed in this realm and what they see for the future of veterinary nutraceuticals.
EP. 6: Second Opinion: Addressing Cancer-Related Fatigue in Integrative Oncology
July 26th 2022
Research Scientist Dr. Dori Beeler, of the Levine Cancer Institute of Atrium Health and corresponding author for the manuscript titled “Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations” that was recently published in the May issue of the journal ONCOLOGY®, was joined by co-authors Dr. Shelley Wang, of The University of Texas MD Anderson Cancer Center, and Dr. Viraj Master, of the Winship Cancer Institute of Emory University, to discuss their research. They touched on challenges in treating patients with cancer-related fatigue, such as the subjective nature of patient-reported outcome measures and the limited ability for cross-comparison across trials. In the paper, the authors compare tools for cancer-related fatigue, considerations for choosing between scales, and how to best implement them into clinical trials and daily practice. The experts provide a broad overview of their research in this episode.
EP. 7: Second Opinion: Pediatric COVID-19 Vaccines
July 14th 2022
The mRNA vaccines by Pfizer BioNTech and Moderna have been approved by the Centers for Disease Control for children as young as 6 months. Today, Contemporary Pediatrics talks with Carlton KK Lee, editor for The Clinical Pharmacologist’s Notebook for Contemporary Pediatrics; Residency Program Director, and associate professor, Department of Pediatrics, John Hopkins Medical Institutions, Baltimore Maryland; and Andrew J. Schuman, clinical assistant professor of pediatrics, Geisel School of Medicine at Dartmouth, Hanover New Hampshire as to who is best equipped to deliver the COVID vaccines to our littlest population.
